Nuveen Asset Management, LLC Kura Oncology, Inc. Transaction History

Nuveen Asset Management, LLC

$334 Billion
Q2 2024

A detailed history of Nuveen Asset Management, LLC transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 262,051 shares of KURA stock, worth $5.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

262,051

Previous 210,166 24.69%

Holding current value

$5.12 Million

Previous $4.48 Million 20.37%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$17.53 - $22.98 $909,544 - $1.19 Million	51,885 Added 24.69%	262,051 $5.4 Million
Q1 2024 May 13, 2024	BUY	$13.42 - $23.53 $144,305 - $253,018	10,753 Added 5.39%	210,166 $4.48 Million
Q4 2023 Feb 14, 2024	SELL	$7.58 - $14.38 $4.03 Million - $7.64 Million	-531,130 Reduced 72.7%	199,413 $2.87 Million
Q3 2023 Nov 14, 2023	BUY	$8.44 - $11.86 $595,737 - $837,138	70,585 Added 10.7%	730,543 $6.66 Million
Q2 2023 Aug 14, 2023	SELL	$9.62 - $13.99 $1,375 - $2,000	-143 Reduced 0.02%	659,958 $6.98 Million
Q1 2023 May 15, 2023	SELL	$10.71 - $14.6 $380,847 - $519,176	-35,560 Reduced 5.11%	660,101 $8.07 Million
Q4 2022 Feb 14, 2023	BUY	$11.23 - $16.9 $3.99 Million - $6 Million	355,277 Added 104.38%	695,661 $8.63 Million
Q3 2022 Nov 14, 2022	BUY	$12.01 - $19.45 $1.37 Million - $2.22 Million	114,042 Added 50.38%	340,384 $4.65 Million
Q2 2022 Aug 15, 2022	SELL	$10.71 - $18.33 $3.2 Million - $5.48 Million	-298,844 Reduced 56.9%	226,342 $4.15 Million
Q1 2022 May 16, 2022	BUY	$11.78 - $16.98 $887,505 - $1.28 Million	75,340 Added 16.75%	525,186 $8.35 Million
Q4 2021 Feb 14, 2022	SELL	$12.22 - $19.57 $241,296 - $386,429	-19,746 Reduced 4.2%	449,846 $6.3 Million
Q3 2021 Nov 12, 2021	BUY	$15.42 - $21.72 $1.48 Million - $2.08 Million	95,684 Added 25.59%	469,592 $8.8 Million
Q2 2021 Aug 16, 2021	BUY	$20.85 - $29.88 $1.75 Million - $2.51 Million	83,989 Added 28.97%	373,908 $7.8 Million
Q1 2021 May 17, 2021	SELL	$24.75 - $39.14 $10.9 Million - $17.3 Million	-441,950 Reduced 60.39%	289,919 $8.2 Million
Q4 2020 May 17, 2021	SELL	$29.0 - $41.62 $678,136 - $973,242	-23,384 Reduced 3.1%	731,869 $23.9 Million
Q4 2020 Feb 16, 2021	SELL	$29.0 - $41.62 $2.38 Million - $3.42 Million	-82,199 Reduced 9.82%	755,253 $24.7 Million
Q3 2020 Nov 16, 2020	BUY	$16.3 - $30.64 $806,458 - $1.52 Million	49,476 Added 6.28%	837,452 $25.7 Million
Q2 2020 Aug 14, 2020	BUY	$7.95 - $18.81 $3.18 Million - $7.53 Million	400,579 Added 103.4%	787,976 $12.8 Million
Q1 2020 May 14, 2020	BUY	$6.45 - $14.04 $513,671 - $1.12 Million	79,639 Added 25.88%	387,397 $3.85 Million
Q4 2019 Feb 14, 2020	SELL	$12.97 - $15.94 $983,151 - $1.21 Million	-75,802 Reduced 19.76%	307,758 $4.23 Million
Q3 2019 Nov 14, 2019	BUY	$14.75 - $20.87 $4.23 Million - $5.98 Million	286,685 Added 295.93%	383,560 $5.82 Million
Q2 2019 Aug 15, 2019	BUY	$14.71 - $19.79 $1.43 Million - $1.92 Million	96,875 New	96,875 $1.91 Million

Others Institutions Holding KURA

# of Institutions

181

Shares Held

80.2M

Call Options Held

148K

Put Options Held

63K

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $1.31B
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Kura Oncology, Inc. Transaction History